SELECT MEDICAL CORP

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

1.02

Certification of termination of registration of a class of securities (Section 12(b))

5.02

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

1.01,2.03,8.01,9.01

5.02,7.01,9.01

1.01,8.01,9.01

7.01,8.01,9.01

2.02,9.01

7.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

5.07

1.01,2.03,9.01

5.02

7.01,9.01

7.01,9.01

Annual report pursuant to Section 13 or 15(d)

2.02,9.01

7.01,9.01

7.01,9.01

8.01,9.01

8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Annual report pursuant to Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Letter from the SEC

Letter from the SEC

Certification of termination of registration of a class of securities (Section 12(b))

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notification of the removal from listing and registration of matured redeemed or retired securities

Certification of termination of registration of a class of securities (Section 12(b))

No description available

Correspondence with the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

No description available

Letter from the SEC

No description available

Registration of Securities on Exchange (amendment)

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Definitive Proxy Statement

Registration of Securities on Exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Definitive Proxy Statement

SELECT MEDICAL CORP

SELECT MEDICAL CORP

SELECT MEDICAL CORP

SELECT MEDICAL CORP

RICE PATRICIA A

TALALAI JAMES J

ROMBERGER SCOTT A

DALTON JAMES E JR

CHERNOW DAVID S

ZIMMERMAN LEROY S

FELDBERG MEYER

SWERGOLD LEOPOLD

SCULLY THOMAS A

ORTENZIO ROBERT A